Related Experiment Video
Updated: Jun 7, 2026
03:08
Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
Recent progress in automatically extracting information from the pharmacogenomic literature
Yael Garten1, Adrien Coulet, Russ B Altman
1Biomedical Informatics, Stanford University, Stanford, CA 94305, USA.
Pharmacogenomics
|November 5, 2010
Summary
Organizing pharmacogenomic knowledge from dispersed literature is crucial. Text mining creates structured databases, enabling new insights and hypothesis generation from biomedical publications.
Area of Science:
- Biomedical Informatics
- Pharmacogenomics
- Text Mining
Background:
- Pharmacogenomic knowledge is fragmented across numerous scientific journals.
- Integrating this dispersed information is essential for advancing research and generating novel hypotheses.
- Structured databases are needed to unlock the full potential of the biomedical literature.
Purpose of the Study:
- To describe the primary tasks of text mining within pharmacogenomics.
- To summarize recent advancements and applications of text mining in this field.
- To forecast future directions for text mining in pharmacogenomics.
Main Methods:
- Utilizing text mining techniques to automatically structure unstructured knowledge from millions of publications.
- Focusing on methods applicable to the pharmacogenomics literature.
- Enabling extraction of specific information and answering systemic queries.
Main Results:
- Text mining facilitates the creation of structured pharmacogenomic knowledge databases.
- These databases enhance the value of individual reports by enabling integration and hypothesis generation.
- Applications include generating candidate gene lists and interpreting genome-wide association study results.
Conclusions:
- Text mining is a powerful tool for organizing and leveraging the vast biomedical literature in pharmacogenomics.
- Structured knowledge extraction advances our understanding and application of pharmacogenomic data.
- Continued development in text mining will drive future discoveries in personalized medicine.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:28Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...